| DIRECT COMPETITOR COMPARISON | |
| MDCO | Pvt1 | GSK | PFE | Industry | | Market Cap: | 425.61M | N/A | 108.68B | 149.21B | 167.80M | | Employees: | 453 | N/A | 99,003 | 81,800 | 95 | | Qtrly Rev Growth (yoy): | 12.10% | N/A | 14.90% | -2.90% | 20.50% | | Revenue (ttm): | 396.05M | N/A | 45.19B | 45.82B | 46.74M | | Gross Margin (ttm): | 71.67% | N/A | 76.27% | 86.61% | 68.58% | | EBITDA (ttm): | 10.76M | N/A | 17.81B | 21.31B | -6.21M | | Oper Margins (ttm): | 1.37% | N/A | 34.30% | 37.42% | 2.25% | | Net Income (ttm): | -6.93M | N/A | 8.12B | 8.09B | N/A | | EPS (ttm): | -0.133 | N/A | 3.18 | 1.204 | -0.17 | | P/E (ttm): | N/A | N/A | 13.48 | 15.36 | 18.61 | | PEG (5 yr expected): | N/A | N/A | 3.01 | 5.9 | 1.00 | | P/S (ttm): | 1.03 | N/A | 2.37 | 3.22 | 4.40 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.27 | 0.83% | 57.97B | 12.49 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.46 | 0.17% | 13.73B | 15.88 | | Genzyme Corp. | GENZ | 51.41 | 2.04% | 13.64B | 29.31 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 47.01 | 0.11% | 42.31B | 18.18 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.85 | 1.34% | 9.07B | 1037.76 | | Teva Pharmaceutical Industries Limited | TEVA | 53.15 | -0.23% | 46.83B | 48.63 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.73 | 1.84% | 4.00B | 19.45 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.11 | 0.25% | 3.01B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.31 | 0.05% | 5.60B | 112.33 | | Pfizer Inc. | PFE | 18.49 | 0.98% | 149.21B | 15.36 | | Johnson & Johnson | JNJ | 63.31 | 0.21% | 174.68B | 13.83 | | GlaxoSmithKline plc | GSK | 42.87 | 1.40% | 108.68B | 13.48 | | Sanofi-Aventis | SNY | 39.421 | 2.05% | 102.93B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.86 | 1.01% | 126.87B | 16.72 | | RHHBY.PK | 42.20 | 1.81% | N/A | N/A | | AstraZeneca plc | AZN | 46.4596 | 2.67% | 67.37B | 9.33 | | Abbott Laboratories | ABT | 54.40 | 0.29% | 84.14B | 14.74 | | Bristol-Myers Squibb Co. | BMY | 25.58 | 1.67% | 50.67B | 13.23 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|